166 related articles for article (PubMed ID: 12446967)
1. Cholinergic regulation of synaptic plasticity as a therapeutic target in Alzheimer's disease.
Small DH; Fodero LR
J Alzheimers Dis; 2002 Oct; 4(5):349-55. PubMed ID: 12446967
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease.
Jürgensen S; Ferreira ST
J Mol Neurosci; 2010 Jan; 40(1-2):221-9. PubMed ID: 19690986
[TBL] [Abstract][Full Text] [Related]
3. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
[TBL] [Abstract][Full Text] [Related]
4. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
Lombardo S; Maskos U
Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
[TBL] [Abstract][Full Text] [Related]
5. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
Ni R; Marutle A; Nordberg A
J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
Shen J; Wu J
Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
[TBL] [Abstract][Full Text] [Related]
7. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
[TBL] [Abstract][Full Text] [Related]
8. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.
Parri HR; Hernandez CM; Dineley KT
Biochem Pharmacol; 2011 Oct; 82(8):931-42. PubMed ID: 21763291
[TBL] [Abstract][Full Text] [Related]
9. On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease.
Oz M; Lorke DE; Yang KH; Petroianu G
Curr Alzheimer Res; 2013 Jul; 10(6):618-30. PubMed ID: 23627750
[TBL] [Abstract][Full Text] [Related]
10. Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo.
Wu MN; He YX; Guo F; Qi JS
Brain Res Bull; 2008 Sep; 77(2-3):84-90. PubMed ID: 18602971
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function.
Ari C; Borysov SI; Wu J; Padmanabhan J; Potter H
Neurobiol Aging; 2014 Aug; 35(8):1839-49. PubMed ID: 24636920
[TBL] [Abstract][Full Text] [Related]
13. Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia.
Woodruff-Pak DS; Gould TJ
Behav Cogn Neurosci Rev; 2002 Mar; 1(1):5-20. PubMed ID: 17715584
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Relationship Between Cognitive Impairment, Glycometabolism, and Nicotinic Acetylcholine Receptor Deficits in a Mouse Model of Alzheimer's Disease.
Matsuura Y; Ueda M; Higaki Y; Sano K; Saji H; Enomoto S
Mol Imaging Biol; 2019 Jun; 21(3):519-528. PubMed ID: 30047036
[TBL] [Abstract][Full Text] [Related]
15. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
[TBL] [Abstract][Full Text] [Related]
16. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells.
Guan ZZ; Miao H; Tian JY; Unger C; Nordberg A; Zhang X
J Neural Transm (Vienna); 2001; 108(12):1417-33. PubMed ID: 11810405
[TBL] [Abstract][Full Text] [Related]
17. Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta.
Magdesian MH; Nery AA; Martins AH; Juliano MA; Juliano L; Ulrich H; Ferreira ST
J Biol Chem; 2005 Sep; 280(35):31085-90. PubMed ID: 15987688
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.
Auld DS; Kornecook TJ; Bastianetto S; Quirion R
Prog Neurobiol; 2002 Oct; 68(3):209-45. PubMed ID: 12450488
[TBL] [Abstract][Full Text] [Related]
19. Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer's disease treatment.
Gazova Z; Soukup O; Sepsova V; Siposova K; Drtinova L; Jost P; Spilovska K; Korabecny J; Nepovimova E; Fedunova D; Horak M; Kaniakova M; Wang ZJ; Hamouda AK; Kuca K
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):607-619. PubMed ID: 27865910
[TBL] [Abstract][Full Text] [Related]
20. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
